Connect with us

Technology

RoboSense Reports 2026 Interim Results, with Robotics LiDAR Sales Volume Up 510.4% Year over Year

Published

2 hours ago

on

H1 2026 revenue increased 30.2% year over year to RMB 1.02 billion.Total LiDAR sales volume rose 169.6% year over year to 719,200 units.LiDAR sales volume for robotics and other applications increased 510.4% year over year to 282,600 units.RoboSense expanded its product matrix beyond LiDAR into three robotics component categories — “Eyes,” “Skin,” and “Muscles” — with the first commercial deliveries of new products beginning in Q3 2026.

HONG KONG, Aug. 27, 2026 /PRNewswire/ — RoboSense Technology Co., Ltd. (“RoboSense” or the “Company”; stock code: 2498.HK), a pioneering robotics platform company for Physical AI, has officially released its 2026 interim results.

In the first half of 2026, the Company’s growth momentum continued to build, with total revenue reaching approximately RMB 1.02 billion, a year-over-year increase of 30.2%. This momentum was primarily driven by the robotics business: total LiDAR shipments reached 719,200 units, up 169.6% YoY, with robotics LiDAR shipments alone climbing to 282,600 units, up 510.4% YoY, further cementing its position as the Company’s core growth engine for Physical AI.

During the reporting period, the Company continued to advance its digital LiDAR platform in the first half of 2026, unveiling the EOCENE SPAD-SoC architecture alongside two new chipsets, Phoenix and Peacock. As RoboSense’s first mass-production LiDAR model equipped with the self-developed Peacock chipset, E2 has officially launched full-scale volume production and customer delivery. At the same time, the Company is applying its capabilities to a broader range of core robotics components, broadening its portfolio from LiDAR into a wider range of core robotics components.

Mark Qiu, CEO of RoboSense, said: that “2026 marks a pivotal inflection point for RoboSense. Back in 2024, we articulated a new vision: to become a leading robotics-technology platform. Following two years of execution, our ‘eye,’ ‘skin,’ and ‘muscle’ product lines are now moving from development into commercialization, with initial commercial deliveries beginning this year. As this portfolio scales into 2027, it will drive broader growth and profitability for the Company. Historically, RoboSense has been defined by LiDAR. Today, we are re-defining the Company around robotics, focusing on the ‘eyes’ and critical components of ‘hands’ that let robots see clearly, sense precisely, and complete real-world tasks.”

Three New Robotics Component Categories Enter Commercialization

The Company’s H1 2026 results also marked commercialization progress across three new component categories for embodied robots — “eyes,” “skin,” and “muscles” — extending the Company’s reach beyond LiDAR.

Eyes. The Space Camera, publicly demonstrated at ICRA and WAIC in both head-mounted and wrist-mounted configurations, is also deployed in data-collection systems. Customer deliveries begin by the end of Q3 2026, ahead of full-scale production in 2027.Skin. Visual-tactile and MEMS tactile sensors have completed development, with the first enterprise-scale program entering commercial delivery by the end of September and reaching SOP in Q4 2026.Muscles. The Company’s first joint module has likewise completed development, with volume deliveries set to begin in Q4 2026.

These products can be deployed directly on robots, and are equally used in data-collection systems to support hand-eye coordination during data capture.

Business Outlook

In the second half of 2026, the Company will continue to iterate and improve its SPAD-SoC chips built on the EOCENE architecture. Drawing on these, and ongoing chip-level upgrades, the Company will keep launching industry-leading digital LiDAR products to satisfy the market’s rapidly rising demand for LiDAR solutions.

For its “eye” product line — the Space Camera — the Company will complete additional customer testing and drive further project conversions. Turning to its “skin” product line, visual-tactile and MEMS tactile sensors are scheduled to commence product deliveries in the third quarter of 2026. For its “muscles” product line, volume delivery will commence in the fourth quarter of 2026.

In 2027, the Company’s growing suite of robotic products is expected to drive further customer wins and expanded product deliveries, which in turn will help fuel broader-based growth across the robotics business. As the robotics business scales, it will also serve as an ongoing driver for the Company’s profitability.

Historically, RoboSense has been defined by its LiDAR offerings. Today, the Company is re-defining itself around robotics. While computing power and models enable robots to think, it is robotic eyes and hands that determine real-world task execution. RoboSense will not manufacture every single robot component. Instead, the Company will focus its resources on developing the most critical upper-body robotic building blocks: “eyes” and critical components of hands (“skin” and “muscles”). Its goal is to enable robots to see clearly, sense precisely, grip firmly, and complete real-world tasks.

Since June 30, 2026 and up to the date of this announcement, there has been no material adverse change in the Company’s financial or trading position or prospects, and no event that would materially affect the information set out in the Group’s consolidated financial statements in this announcement.

About RoboSense

RoboSense (HKEX: 02498) is a pioneering robotics platform company for Physical AI. Based on its in-house optoelectronic chips and perception algorithms, and supported by its scaled mass production capabilities, RoboSense provides robots with core components and infrastructure, including LiDAR and Space Camera. Its products have been deployed at scale across more than ten application areas, including smart vehicles, Robotaxi, robotic lawn mowers, autonomous logistics, embodied intelligence, and commercial cleaning robots. RoboSense serves more than 3,400 robotics clients worldwide and is ranked No. 1 globally in robotics LiDAR market share in 2025.

View original content to download multimedia:https://www.prnewswire.com/news-releases/robosense-reports-2026-interim-results-with-robotics-lidar-sales-volume-up-510-4-year-over-year-302861445.html

SOURCE RoboSense Technology Co., Ltd.

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Bittium launches new Faros Pro™ ECG device and EasyFlex™ single-use electrode patch for long-term ambulatory ECG monitoring

Published

36 minutes ago

on

August 27, 2026

By

Bittium Corporation press release on August 27, 2026, at 9.00 am

OULU, Finland, Aug. 27, 2026 /PRNewswire/ — Bittium today launches Bittium Faros Pro™, a new ambulatory ECG device designed for long-term ECG recording, together with Bittium EasyFlex™, a single-use one-lead electrode patch. Faros Pro marks a significant new ambulatory ECG device launch for Bittium outside the United States. It is also an important step in renewing the company’s product portfolio and strengthening its international ECG offering.

Bittium Faros Pro is built to capture high-quality, accurate ECG signals while patients continue their daily lives. High-quality signals and longer recording periods help healthcare professionals detect intermittent arrhythmias, understand each patient’s heart and make more confident care decisions.

Turning signals into answers

The quality of the measured ECG signal is critical when healthcare professionals make decisions about patient care. Faros Pro builds on Bittium’s decades of expertise in physiological signal measurement and medical technology development.

Faros devices have been used as the gold standard in clinical studies comparing heart-rate measurement accuracy. More than 600,000 Faros devices have been delivered to over 40 countries. Faros Pro builds on this strong foundation and supports reliable long-term ECG recording.

Because arrhythmias happen when life happens

Faros Pro and the EasyFlex electrode patch are designed to let patients continue their normal daily activities during ambulatory ECG monitoring. Faros Pro enables long-term ambulatory ECG monitoring with continuous ECG recording for periods ranging from 24 hours to 30 days. It provides up to 21 days of recording on a single charge, depending on the device settings used.

Long-term ECG recording gives healthcare professionals more opportunities to capture intermittent heart rhythm events that shorter recordings may miss.¹ Earlier detection can help healthcare professionals start the right care sooner. This can reduce the risk of serious complications, including stroke.

“This is an important launch for Bittium Medical. We combine decades of experience in biosignal measurement with patient-friendly devices. Clinically validated ECG devices provide reliable data that help healthcare professionals make more confident care decisions for patients with heart rhythm disorders. Longer recordings provide more opportunities to detect arrhythmias that may otherwise be missed in shorter examinations. This can help patients get answers about their health sooner,” says Niina Huikuri, Senior Vice President, Medical Business Segment. “Faros Pro demonstrates our ability to develop trusted medical technology and strengthens our offering in international long-term ECG recording markets. In line with our strategy, we will continue to advance ECG technology, with the aim of bringing increasingly cutting edge ECG technology to market in the future.”

Bittium Faros Pro is CE marked in accordance with the EU Medical Device Regulation (EU) 2017/745 (MDR). Product availability may vary by market. Bittium Faros Pro and Bittium EasyFlex will be presented at ESC Congress 2026 in Munich, Germany, at Bittium booth M300.

Read more about Bittium Faros Pro: www.bittium.com/medical/bittium-faros/

Further information:

Niina Huikuri
Senior Vice President, Medical Business Segment
Tel. +358 40 344 2789 (group communications)
Email: medical@bittium.com

Distribution

Nasdaq Helsinki Ltd
Main media

Bittium Medical

At Bittium Medical, reliable data is the starting point for better care. We combine decades of expertise in biosignal measurement with patient-friendly devices, advanced analysis software, and secure cloud-based services for cardiac and sleep apnea diagnostics. Our clinically validated ECG devices are the gold standard in long-term ECG recording, high-quality signals, patient comfort and reliable data for clinical review. By bringing diagnostics closer to the patient and supporting efficient clinical workflows, we help healthcare professionals make more confident decisions and deliver better care.

www.bittium.com/medical

Bittium

Bittium specializes in the development of reliable, secure communications and connectivity solutions leveraging its 40-year legacy of expertise in advanced radio communication technologies. Bittium provides innovative products and services, customized solutions based on its product platforms and R&D services. Complementing its communications and connectivity solutions, Bittium offers proven information security solutions for mobile devices and portable computers. Bittium also provides healthcare technology products and services for biosignal measuring in the areas of cardiology and neurophysiology. Bittium’s net sales in 2025 were EUR 119.3 million and operating profit EUR 19.4 million. Bittium is listed on Nasdaq Helsinki. www.bittium.com

References

1. Liu CM et al. Enhanced detection of cardiac arrhythmias utilizing 14-day continuous ECG patch monitoring. International Journal of Cardiology. 2021;332:78-84. https://pubmed.ncbi.nlm.nih.gov/33727122/ 

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/bittium-oyj/r/bittium-launches-new-faros-pro–ecg-device-and-easyflex–single-use-electrode-patch-for-long-term-am,c4388418

The following files are available for download:

View original content:https://www.prnewswire.co.uk/news-releases/bittium-launches-new-faros-pro-ecg-device-and-easyflex-single-use-electrode-patch-for-long-term-ambulatory-ecg-monitoring-302861467.html

Continue Reading

Technology

Deakin’s India-Focused Research Secures Major Australia-India Grants to Advance Cyber and Critical Technology Innovation

Published

36 minutes ago

on

August 27, 2026

By

NEW DELHI, Aug. 27, 2026 /PRNewswire/ — Deakin University, Australia, celebrates its outstanding researchers who are shaping the future of Australia–India collaboration. Through the success of multiple competitive grant awards, they are accelerating research excellence, pioneering innovation, and strengthening the flow of talent, ideas, and opportunities across borders.

Building on Deakin’s pioneering bilateral contribution, researchers from the Deakin Cyber Research and Innovation Hub and the Deakin Applied Artificial Intelligence Initiative have received funding under the Australia–India Cyber and Critical Technology Partnership (AICCTP). The projects bring together researchers from Deakin and leading Indian and South Asian institutions to tackle pressing cyber and critical technology challenges facing the Indo-Pacific.

Established in 2020, the Australia–India Cyber and Critical Technology Partnership (AICCTP) supports collaboration between Australian and Indian research, industry, government and civil society organisations. The latest awards highlight the role of bilateral research talent in advancing innovation, technological resilience and bilateral cooperation.

The funded projects focus on:

Post-Quantum Cryptography Migration in the Indo-Pacific, led by Deakin in partnership with IIT Madras.Quantum-safe Digital Public Infrastructure, led by Deakin in collaboration with Symbiosis International University and VIT.Securing Critical Energy Supply Chains Using AI and Blockchain, led by La Trobe University in collaboration with Deakin and IIT Kanpur.Addressing Barriers to Safe, Standards-Based AI Adoption, led by Swinburne University of Technology in collaboration with Deakin, IIT Palakkad, River Venture Studio (Singapore), Kumaraguru College of Technology

Professor Robin Doss, Director of the Deakin Cyber Research and Innovation Hub, said, “Australia and India share an increasingly important partnership built on knowledge, innovation and talent. These projects reflect the depth of that relationship and our shared commitment to developing secure, resilient and future-ready technologies that will benefit both nations and the broader Indo-Pacific region.”

These latest grants complement Deakin’s broader commitment to building innovation-led partnerships. Earlier, the Deakin SME Research Centre secured an A$340,000 Australian Government Maitri Grant for the initiative, Empowering Innovation: Australian FDI Initiatives for Building Innovation Centres in India, designed to help Australian SMEs better understand India’s innovation landscape through workshops, policy insights and an India roadshow.

“At Deakin, we believe the strongest impact comes from bringing great talent and partners together. Our work across Australia and India is about co-creating solutions that build capability, drive innovation and deliver real benefits for communities and industry,” Ravneet Pawha, Vice President (Global Engagement) and CEO (South Asia), Deakin University, mentioned while welcoming these awards.

These collaborations reflect the growing ambition of the Australia–India partnership in critical technologies, research and innovation, bringing together universities, industry and research institutions to advance areas such as AI, cybersecurity and quantum technologies while strengthening talent mobility and innovation pathways between the two countries.

As Australia and India deepen cooperation in strategic sectors, Deakin remains committed to fostering partnerships that drive innovation, build capability and deliver lasting benefits for industry, governments and communities.

To learn more about Deakin’s cutting-edge cyber and critical technology innovation and how you can participate, please visit the Deakin Cyber Research and Innovation Centre

About Deakin University: Established in 1974, Deakin University successfully combines excellence in teaching, research and effective partnerships with industry and government to deliver high-quality courses and undertake research that makes a difference to the domestic and international communities it serves.

Deakin’s South Asia operations commenced in 1994 at New Delhi, India, making it one of the first overseas education providers to set up operations in this region. Here, Deakin engages with the government, industry, and academia to share its vibrant culture of education and research.

To know more about Deakin University and its various initiatives as part of its ‘in India, with India, for India’ approach towards engagement, please visit https://www.deakin.edu.au/ 

 

 

View original content to download multimedia:https://www.prnewswire.com/in/news-releases/deakins-india-focused-research-secures-major-australiaindia-grants-to-advance-cyber-and-critical-technology-innovation-302861502.html

Continue Reading

Technology

InCred Capital launches InCred Black in major UHNI Push

Published

36 minutes ago

on

August 27, 2026

By

Alok Agrawal, Harmeet Sahney and Zarksis Gotla join as Co-Founders as InCred sharpens and scales its offering for India’s UHNI segment

MUMBAI, India, Aug. 27, 2026 /PRNewswire/ — InCred Capital today announced the launch of InCred Black, a focused proposition for ultra-high-net-worth individuals, entrepreneurs and business families, with Alok Agrawal, Harmeet Sahney and Zarksis Gotla joining as Co-Founders.

InCred Black brings together highly personalised wealth management services and access to capabilities across asset allocation, alternatives, public and private markets, credit, liquidity solutions and global investing – backed by the broader investment, advisory and institutional strengths of InCred Capital and the InCred Group.

Agrawal, Sahney and Gotla are credited with building the wealth business at Avendus over the last 15 years and bring over 80 years of collective experience at firms such as Kotak, Barclays and Credit Suisse, advising some of India’s most prominent UHNI clients. They will play a central role in shaping InCred Black, deepening client relationships and expanding the team as InCred Black scales.

The launch comes on the back of InCred’s substantial Wealth franchise, which has crossed ₹1 lakh crore in AUM and already serves a large UHNI client base. InCred Black extends that foundation with a sharper, more differentiated offering for this segment, while its specialist capabilities, senior talent and access will also strengthen the broader Wealth offering and benefit existing Wealth clients where relevant.

Bhupinder Singh, Founder & Group CEO, InCred, said, “We’ve built a powerful wealth franchise with deep client relationships and significant scale. InCred Black raises the bar further – bringing a sharper proposition, differentiated access and the full capabilities of InCred to our most sophisticated clients, while strengthening the broader wealth management platform.”

Nitin Rao, CEO of InCred Wealth, added, “InCred Black adds further depth to an already strong Wealth franchise. It gives our UHNI relationships greater specialisation, while the talent, ideas and access it brings will strengthen what we can offer clients across the platform.”

InCred Black will continue to add senior bankers and specialist talent as it scales. The ambition is clear – to make InCred the trusted first call for India’s leading UHNI families.

 

 

View original content to download multimedia:https://www.prnewswire.com/in/news-releases/incred-capital-launches-incred-black-in-major-uhni-push-302861506.html

Continue Reading

Trending